Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Powerful treatment for IPF stops dangerous scar formation in mouse lungs

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

Existing drug used to treat alcoholism is potentially effective against COVID-19

Existing drug used to treat alcoholism is potentially effective against COVID-19

Study sheds light on potential new treatment approach in AML patients

Study sheds light on potential new treatment approach in AML patients

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

Repurposed drug for acute lung injury in COVID-19

Repurposed drug for acute lung injury in COVID-19

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Repurposing immunosuppressants to manage COVID-19

Repurposing immunosuppressants to manage COVID-19

Targeted therapy shows immense benefit for patients with early stage NSCLC

Targeted therapy shows immense benefit for patients with early stage NSCLC

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

A new combinatorial therapy for treatment of liver cancer

A new combinatorial therapy for treatment of liver cancer

Singapore researchers find common therapeutic vulnerability for a deadly blood cancer

Singapore researchers find common therapeutic vulnerability for a deadly blood cancer

Research could provide more effective way to treat brain swelling after stroke

Research could provide more effective way to treat brain swelling after stroke

Cancer drug shows promise in battling Parkinson’s disease

Cancer drug shows promise in battling Parkinson’s disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Modifying a cancer drug has created a new agent for multi-resistant infections

Modifying a cancer drug has created a new agent for multi-resistant infections

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

Relapsed mantle cell lymphoma patients may benefit from CAR T-cell therapy

Relapsed mantle cell lymphoma patients may benefit from CAR T-cell therapy

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients